Visitors   Views   Downloads

Loss of microbiota depletes cross-reactive Foxp3+ Tregs leading to selective immunopathologies

View preprint
77 days ago
Loss of microbiota depletes cross-reactive Foxp3+ Tregs leading to selective immunopathologies https://t.co/gdwG2ORrqW
NOT PEER-REVIEWED
"PeerJ Preprints" is a venue for early communication or feedback before peer review. Data may be preliminary.

Additional Information

Competing Interests

Tirumalai Kamala and David Usharauli are founders of Tregeutix Inc., a biotech company that focuses on developing microbiota guided antigen-specific immunotherapies.

Author Contributions

Tirumalai Kamala conceived and designed the experiments, analyzed the data, contributed reagents/materials/analysis tools, wrote the paper, prepared figures and/or tables, reviewed drafts of the paper.

David Usharauli conceived and designed the experiments, analyzed the data, contributed reagents/materials/analysis tools, wrote the paper, prepared figures and/or tables, reviewed drafts of the paper.

Data Deposition

The following information was supplied regarding data availability:

Manuscript doesn't contain any raw data/code

Funding

The authors received no funding for this work.


Add your feedback

Before adding feedback, consider if it can be asked as a question instead, and if so then use the Question tab. Pointing out typos is fine, but authors are encouraged to accept only substantially helpful feedback.

Some Markdown syntax is allowed: _italic_ **bold** ^superscript^ ~subscript~ %%blockquote%% [link text](link URL)
 
By posting this you agree to PeerJ's commenting policies